Pathogenic Vibrio cholerae 01 cause disease by colonizing the human small intestine, where they produce a potent enterotoxin (1). Many elements of the vibrio cell surface have been postulated to be involved in colonization, but an actual molecular component or morphological structure responsible for adherence to the human intestinal mucosa has not previously been conclusively demonstrated .
Pathogenic Vibrio cholerae 01 cause disease by colonizing the human small intestine, where they produce a potent enterotoxin (1) . Many elements of the vibrio cell surface have been postulated to be involved in colonization, but an actual molecular component or morphological structure responsible for adherence to the human intestinal mucosa has not previously been conclusively demonstrated .
In the classical Ogawa V . cholerae 01 strain 395, a regulatory protein, ToxR, controls expression of cholera toxin (2) . ToxR also regulates the expression of a rigid pilus, TcpA, in a coordinate manner with cholera toxin (3) . Recently, tc,6A and toxR insertion mutants of V . cholerae Ol were shown to be defective in colonization in suckling mice (3) . To determine the role of TcpA in colonization of the human intestine, the bacteriology, and clinical and immunologic responses of healthy adult volunteers who ingested three Ogawa 395 mutants were assessed .
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Materials and Methods

Brief Definitive Report
Bacterial Strains. Organisms used in this study are listed in Table I . EM of the parent strain 395 shows expression of TcpA filaments, each 5-7 nm in diameter, aggregating to form large bundles (3, 4, Fig. 1 A) . Strain 395-Nl, an isogenic mutant of 395, has an internal deletion in each of the two genes encoding the A subunit of cholera toxin (5) . Strain JJM43, a derivative of 395-NI, carries an additional deletion in the toxR gene leading to markedly decreased expression of TcpA (3) . Strain TCP2, also derived from 395-Nl, carries an internal deletion in the tcpA gene that removes the coding sequence for amino acid residues 119-154 of the 199 residues making up mature TcpA subunits (6) ; consequently, TCP2 produces no pili of this type (Fig. 1 B) .
Volunteers . Adult volunteers between the ages of 18 and 35 from the Baltimore metropolitan area participated in the studies . The methods of medical screening, care of the volunteers, and informed consent have been described (7, 8) . Vaccination and challenge studies were carried out under quarantine in the 32-bed isolation ward maintained by the Center for Vaccine Development in the University of Maryland Hospital (Baltimore, MD) . Pro Specimens of all stools were cultured both quantitatively and qualitatively. If no stool specimen was available in a 24-h period, a rectal swab was obtained. Stool and swabs were directly plated onto thiosulfate-citrate-bile salts-sucrose (TCBS) agar (BBL Microbiology Systems, Cockeysville, MD) and inoculated into alkaline peptone water enrichment broth . After overnight incubation, the enrichment broth was subcultured onto TCBS agar. Quantitative cultures were obtained by diluting 1.0 g (or 1.0 ml) of stool 10-fold serially in PBS (pH 7.2), inoculating 0.1 ml onto plates ofTCBS agar, and counting colonies . Yellow colonies on TCBS agar were confirmed as V. cholerae Ol serotype Ogawa by agglutination with Ogawa typeing sera. Gelatin string capsule devices (Enterotest ; HDC Corp., Mountain View, CA) were used to obtain duodenal fluid for culture (7) . Fasting volunteers ingested string capsules at 6:00 a.m. on two consecutive days after vaccination . Strings were removed 4 h later, and the distal bile-stained portions were cultured as above. If the pH of the fluid obtained from the string was <6, indicating probable gastric origin, negative results were not reported .
Serology. Sera were collected from all volunteers before and 7, 21, and 28 d after ingestion ofall strains . Vibriocidal antibody was measured by a microtiter technique (9) . IgG antitoxin antibodies were measured by ELISA (10).
Results and Discussion
The clinical responses of volunteers to the attenuated strains are summarized in Table II . Strains TCP2 and 395-N1 (at 106 CFU) were compared in a double-blind fashion in the same study. Otherwise, the different strains or different doses of the same strain were tested at separate times . Diarrhea or fever (maximum temperature of39°C) were documented in 3 of 13 volunteers receiving the higher dose of 395-N1 (10 8 viable organisms), and constitutional complaints were noted by approximately half of the recipients of either dose of this strain. Notable adverse reactions were not seen with strains JJM43 and TCP2.
Dramatic differences were seen in the bacteriologic responses to these strains (Table  II) . Recipients of 106 CFU of strains TCP2 or JJM43 never shed the respective organisms in their stool. Strain JJM43 was recovered from the stools of two of seven volunteers receiving 2 x 108 CFU, although duodenal string capsule cultures were negative . In contrast, strain 395-N1 colonized efficiently as determined by coprocultures and cultures of string capsule devices .
20 of 21 recipients of395-N1 had prominent serum vibriocidal antibody responses, including all 13 volunteers who ingested 108 CFU (Table II) . Although 9 of 12 JJM43 recipients also had seroconversions, the geometric mean vibriocidal titers were significantly lower than those seen after ingestion of 395-N1 (Table II) . Likewise, the IgG cholera antitoxin responses elicited by JJM43 were significantly lower when compared with 395-N1 recipients . In distinction, none of eight recipients of TCP2 manifested significant rises in vibriocidal or antitoxin titers. Electron photomicrographs showing V. cholerae Ol Ogawa 395 (A) and TCP2 (B) negatively stained with 1% phosphotungstic acid, pH 6.8 . Bundles of TcpA are present only in strain 395 and are indicated by the arrow.
To assess the induction of protective immunity after immunization with 395-N1 or TCP2, four recipients of 395-N1, three who had received TCP2, and seven control volunteers were challenged with fully toxigenic V . cholerae Ol strain, Ogawa 395.
Recipients of 395-N1 but not TCP2 were protected against clinical cholera (Table III) .
The mechanisms by which V . cholerea 01 adheres to the enterocytes of the human small intestine has been the subject of intense research since it has obvious relevance to vaccine development (1) . Animal models have previously implicated several com- 
ponents of the vibrio surface in attachment and colonization including LPS (11), flagellar sheath and other flagellar proteins (12), a 25-kD outer membrane protein named ompV (13, 14) , as well as other outer membrane proteins (15) 
Summary
Isogenic mutant strains of V . cholerae Ol lacking elements of a genetic regulon controlled by toxR and implicated in virulence were tested in volunteers . A deletion mutation in ctxA, the gene encoding the A subunit of cholera toxin, markedly attenuated disease symptoms without affecting intestinal colonization . Deletion of toxR, the gene encoding the cholera toxin-positive regulatory protein resulted in a diminution in colonizing capacity. A deletion mutation in tcpA, encoding the major subunit of the toxin coregulated pilus (regulated by toxR), abolished the colonizing capacity of this strain. These results show for the first time the role of a specific pilus structure in colonization ofthe human intestine by V. cholerae Ol and exemplify the significance of a genetic regulon in pathogenesis.
